“…In 2002, el-Azhary and Pakzad divided ADM into 3 groups and group 2 is also known as hypomyopathic dermatomyositis (HDM) [2]. HDM, a term first reported by Sontheimer in 1999 [3], is characterized by the presence of typical DM skin lesions for 6 months or longer in individuals who have no muscle weakness but who have some evidence of muscle inflammation upon testing (muscle enzyme levels, electromyogram, muscle biopsy, muscle magnetic resonance imaging) [4]. Juvenile DM (JDM) cases manifesting as eruptions along the Blaschko-line have been reported in a few cases [5,6].…”